Epigenetics,
Год журнала:
2022,
Номер
17(12), С. 1646 - 1660
Опубликована: Март 21, 2022
Immune
cell-type
composition
changes
with
age,
potentially
weakening
the
response
to
infectious
diseases.
Profiling
epigenetics
marks
of
immune
cells
can
help
us
understand
relationship
disease
severity.
We
therefore
leveraged
a
targeted
DNA
methylation
method
study
differences
in
cohort
pneumonia
patients
(both
COVID-19
positive
and
negative)
unaffected
individuals
from
peripheral
blood.
Frontiers in Pharmacology,
Год журнала:
2020,
Номер
11
Опубликована: Дек. 8, 2020
Over
313,000
SARS-CoV-2
positive
cases
have
been
confirmed
in
Italy
as
of
30
September
2020,
and
the
number
deaths
exceeding
thirty-five
thousand
makes
among
list
most
significantly
affected
countries
world.
Such
an
enormous
occurrence
infections
death
raises
urgent
demand
for
effective
available
treatments.
Discovering
cellular/molecular
mechanisms
pathogenicity
is
paramount
importance
to
understand
how
infection
becomes
a
disease
plan
any
therapeutic
approach.
In
this
regard,
we
performed
silico
analysis
predict
putative
virus
targets
evidence
already
therapeutics.
Literature
experimental
results
identified
angiotensin-converting
enzyme
ACE
Spike
proteins
particularly
involved
COVID-19.
Consequently,
investigated
signalling
pathways
modulated
by
two
through
query
miRNet,
platform
linking
miRNAs,
targets,
functions.
Our
bioinformatics
predicted
microRNAs
(miRs),
miR-335-5p
miR-26b-5p,
being
together
with
histone
deacetylate
(HDAC)
pathway.
Notably,
our
ACE/ACE2-ATR1-Cholesterol-HDAC
axis
signals
that
also
matched
some
clinical
data.
We
hypothesize
current
EMA-approved,
off-label
HDAC
inhibitors
(HDACis)
drugs
may
be
repurposed
limit
or
block
host-virus
interactions.
Moreover,
ranked
compounds
provided
further
evaluation
safety,
efficacy,
effectiveness.
Vaccines,
Год журнала:
2020,
Номер
8(4), С. 700 - 700
Опубликована: Ноя. 20, 2020
SARS-CoV2
has
caused
the
current
pandemic
of
new
coronavirus
disease
2019
(COVID-19)
worldwide.
Clinical
outcomes
COVID-19
illness
range
broadly
from
asymptotic
and
mild
to
a
life-threatening
situation.
This
casts
uncertainties
for
defining
host
determinants
underlying
severity.
Recent
genetic
analyses
based
on
extensive
clinical
sample
cohorts
using
genome-wide
association
studies
(GWAS)
high
throughput
sequencing
curation
revealed
errors
gene
loci
associated
with
about
20%
cases.
Significantly,
most
these
critical
are
enriched
in
two
immune
signaling
pathways,
i.e.,
interferon-mediated
antiviral
chemokine-mediated/inflammatory
signaling.
In
line
profiling
studies,
broad
spectrum
could
be
explained
by
immuno-pathological
regulation
immunogenetic
pathways
through
various
epigenetic
mechanisms,
which
further
interconnect
other
vital
components
such
as
those
renin–angiotensin–aldosterone
system
(RAAS)
because
its
direct
interaction
virus
causing
COVID-19.
Together,
key
genes
unraveled
may
provide
targets
precisely
early
risk
diagnosis
prophylactic
design
relieve
severe
The
confounding
mechanisms
understanding
broadness
illness.
International Journal of Biological Sciences,
Год журнала:
2022,
Номер
18(12), С. 4731 - 4743
Опубликована: Янв. 1, 2022
The
ongoing
COVID-19
pandemic
is
caused
by
an
RNA
virus,
SARS-CoV-2.The
genome
of
SARS-CoV-2
lacks
a
nuclear
phase
in
its
life
cycle
and
replicated
the
cytoplasm.However,
interfering
with
trafficking
using
pharmacological
inhibitors
greatly
reduces
virus
infection
replication
other
coronaviruses
blocked
enucleated
cells,
suggesting
critical
role
nucleus
infection.Here,
we
summarize
alternations
pathways
SARS-CoV-2,
including
translocation
pathways,
innate
immune
responses,
mRNA
metabolism,
epigenetic
mechanisms,
DNA
damage
response,
cytoskeleton
regulation,
rupture.We
consider
how
these
contribute
to
discuss
therapeutic
treatments
that
target
focusing
on
small
molecule
drugs
are
being
used
clinical
studies.
Environmental Science and Pollution Research,
Год журнала:
2021,
Номер
28(39), С. 54209 - 54221
Опубликована: Авг. 12, 2021
COVID-19
pandemic
waves
hitting
worldwide
result
in
drastic
postinfection
complications
with
interindividual
variations,
which
raised
the
question
for
cause
of
these
observed
variations.
This
urged
to
think
"the
impact
environment-affected
genes"?
In
an
attempt
unravel
genes,
a
systematic
rapid
review
was
conducted
study
host
or
viral
epigenetic
modulation
on
infection
susceptibility
and/or
outcome."
Electronic
databases
including
Web
Science,
SCOPUS,
Cochrane
Central
Register
Controlled
Trials,
PubMed,
and
Google
Scholar,
other
were
searched.
The
search
strings
included
"COVID-19"
OR
"SARS-CoV-2"
AND
(Epigenetics').
Articles
randomized
clinical
trials
(RCTs)
observational
designs,
humans
available
English
language,
selected,
respect
"The
interplay
between
SARS-CoV-2
virus
Epigenetics"
published
from
2020
February
2021
(but
not
limited
2020,
being
expanded
2015).
Database
yielded
1330
articles;
after
screening,
exclusion,
further
filtrations,
51
articles
included.
Susceptibility
is
related
viral-microRNAs
(miRNAs)
alter
virulence
transmitted
strains
host-miRNA-related
innate
immunity.
Host-DNA
methylation
chromatin
remodeling
may
be
implicated
severe
cytokine
storm
that
can
ultimately
results
fatal
outcome.
Biomedicine & Pharmacotherapy,
Год журнала:
2021,
Номер
143, С. 112095 - 112095
Опубликована: Авг. 30, 2021
Angiotensin-converting
enzyme-2
(ACE2)
is
one
of
the
major
components
renin-angiotensin
system
(RAS)
and
participates
in
physiological
functions
cardiovascular
lungs.
Recent
studies
identified
ACE2
as
receptor
for
S-protein
novel
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
thus
acts
gateway
viral
entry
into
human
body.
Virus
infection
causes
an
imbalance
RAS
axis
induces
lungs
injury
fibrosis.
Various
factors
regulate
expression
patterns
well
control
its
epigenetic
status
at
both
transcription
translational
levels.
This
review
mainly
focused
on
impact
environmental
toxicants,
drugs,
endocrine
disruptors,
hypoxia
controlling
parameters
possible
modulation
by
changes
which
are
marked
DNA
methylation,
histone
modifications,
micro-RNAs
(miRNAs)
profile.
Furthermore,
we
have
emphasized
interventions
various
phytochemicals
bioactive
compounds
epidrugs
that
ACE2-S-protein
interaction
thereby
curb
infection.
Since
important
component
RAAS
a
crucial
point
SARS-CoV-2,
dynamics
response
to
extrinsic
intrinsic
contemporary
relevance.
We
collated
updated
information
modulated
epidrugs,
urge
take
over
further
these
regulators
unravel
many
more
systemic
linkages
related
metabolic
infectious
diseases,
general
SARS-CoV-2
particular
development
targeted
interventions.
Pathogens,
Год журнала:
2022,
Номер
11(5), С. 516 - 516
Опубликована: Апрель 26, 2022
With
the
onset
of
COVID-19
pandemic,
enormous
efforts
have
been
made
to
understand
genus
SARS-CoV-2.
Due
high
rate
global
transmission,
mutations
in
viral
genome
were
inevitable.
A
full
understanding
and
its
possible
changes
represents
one
crucial
aspects
pandemic
management.
Structural
protein
S
plays
an
important
role
pathogenicity
SARS-CoV-2,
occurring
at
this
level
leading
forms
with
increased
affinity
for
ACE2
receptors,
higher
transmissibility
infectivity,
resistance
neutralizing
antibodies
immune
escape,
increasing
risk
infection
disease
severity.
Thus,
five
variants
concern
are
currently
being
discussed,
Alpha,
Beta,
Gamma,
Delta
Omicron.
In
present
review,
a
comprehensive
summary
following
critical
regarding
SARS-CoV-2
has
made:
(i)
genomic
characteristics
SARS-CoV-2;
(ii)
pathological
mechanism
penetration
into
cell
action
on
specific
receptors;
(iii)
genome;
(iv)
implications
diagnosis,
treatment,
vaccination.
Human Vaccines & Immunotherapeutics,
Год журнала:
2021,
Номер
17(9), С. 2841 - 2850
Опубликована: Май 28, 2021
The
COVID-19
pandemic
has
disrupted
life
throughout
the
world.
Newly
developed
vaccines
promise
relief
to
people
who
live
in
high-income
countries,
although
and
expensive
new
treatments
are
unlikely
arrive
time
help
low-and
middle-income
countries.
pathogenesis
of
is
characterized
by
endothelial
dysfunction.
Several
widely
available
drugs
like
statins,
ACE
inhibitors
(ACEIs)
angiotensin
receptor
blockers
(ARBs)
have
immunometabolic
activities
that
(among
other
things)
maintain
or
restore
cell
function.
For
this
reason,
we
undertook
an
observational
study
four
Belgian
hospitals
determine
whether
in-hospital
treatment
with
these
could
improve
survival
959
patients.
We
found
statins
ACEIs/ARBs
reduced
28-day
mortality
hospitalized
Moreover,
combination
resulted
a
3-fold
reduction
odds
hospital
(OR
=
0.33;
95%
CI
0.17–0.69).
These
findings
were
general
agreement
published
studies.
Additional
studies
clinical
trials
needed
convincingly
show
ACEIs/ARBs,
especially
their
saves
lives.